Workflow
海利生物(603718.SH):2025年中报净利润为1823.48万元

Group 1 - Company reported a total revenue of 110 million yuan, ranking 9th among disclosed peers [1] - The net profit attributable to shareholders was 18.23 million yuan, also ranking 9th among disclosed peers [1] - The net cash inflow from operating activities was 38.12 million yuan, ranking 7th among disclosed peers [1] Group 2 - The latest debt-to-asset ratio is 5.51% [3] - The latest gross profit margin is 77.11% [3] - The latest return on equity (ROE) is 1.15%, ranking 8th among disclosed peers, a decrease of 0.05 percentage points compared to the same period last year [3] Group 3 - The diluted earnings per share is 0.03 yuan, ranking 9th among disclosed peers [4] - The latest total asset turnover ratio is 0.06 times, ranking 11th among disclosed peers, a decrease of 0.01 times, representing a year-on-year decline of 9.39% [4] - The latest inventory turnover ratio is 0.43 times, ranking 11th among disclosed peers, a decrease of 0.12 times, representing a year-on-year decline of 21.24% [4] Group 4 - The number of shareholders is 31,600, with the top ten shareholders holding 329 million shares, accounting for 50.20% of the total share capital [4] - The largest shareholder is Shanghai Haoyuan Venture Capital Development Co., Ltd., holding 34.50% [4]